Showing results (121-130 of 278) with videos related to

Sort By:
Pageof 28
Biorxiv : the Preprint Server for Biology|August 7, 2023
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Kara Anasti, et al.
Journal of Virology|April 20, 2012
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replicationStephanie A Freel, Ralph A Picking, Guido Ferrari, et al.
The Journal of Infectious Diseases|September 2, 2005
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjectsPaul A Goepfert, Helen Horton, M Juliana McElrath, et al.
Research Square|April 25, 2024
B cell immunofocusing and repriming in two HIV-1 Env immunization regimensJenna M DeLuca, Maria Blasi, Shalini Jha, et al.
Journal of Virology|March 8, 2019
Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal ModelsJustin Pollara, Dorothy I Jones, Tori Huffman, et al.
AIDS Research and Human Retroviruses|March 19, 2017
HIV-1 Consensus Envelope-Induced Broadly Binding AntibodiesR Ryan Meyerhoff, Richard M Scearce, Damon F Ogburn, et al.
AIDS (London, England)|August 11, 2020
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infectionCynthia L Gay, Dayna T Neo, Aaron S Devanathan, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killingJoyce K Hwang, Daniel J Marston, Daniel Wrapp, et al.
Pageof 28